Skip to main content
TipRanks
Go Ultimate75% OFF

John G. Aunins Insider Profile

4 Followers

John G. Aunins, Chief Technology Officer & EVP at Seres Therapeutics, holds 105.25K shares in Seres Therapeutics (Ticker: MCRB).

John G. Aunins's Trading History

MCRB
Seres Therapeutics
Jan 28, 2020Chief Technology Officer & EVPUninformative Buy39.13K$148.40K
MCRB
Insider Shares: 105.25K (0.15%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 28, 2020Uninformative Buy$39.13K12,500$3.13―
Jan 29, 2019Uninformative Buy$45.08K7,500$6.01―
Dec 19, 2018Uninformative Sell$91.26K14,282$6.39―
Dec 19, 2018Uninformative Buy$58.50K10,000$5.85―
Nov 19, 2018Uninformative Sell$117.80K14,279$8.25―

You May Also Like

John G. Aunins insider profile FAQ

What is the percentage of profitable transactions made by John G. Aunins?
The percentage of profitable transactions made by John G. Aunins is 100%.
What is the average return per transaction made by John G. Aunins?
The average return per transaction made by John G. Aunins is 45.50%.
What stocks does John G. Aunins hold?
John G. Aunins holds: MCRB stocks.
What was John G. Aunins’s latest transaction?
John G. Aunins’s latest transaction was an Uninformative Buy of $39.13K.
What was John G. Aunins's most profitable transaction?
John G. Aunins’s most profitable transaction was an Informative Sell of MCRB stock on December 20, 2017. The return on the trade was 50.00%.
What is John G. Aunins's role in Seres Therapeutics?
John G. Aunins's role in Seres Therapeutics is Chief Technology Officer & EVP.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.